MIC
ELV icon

Meridian Investment Counsel’s Elevance Health ELV Stock Holding History

Meridian Investment Counsel’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-480
Closed -$260K – 215
2024
Q2 		$260K Hold
480
– – 0.08% 188
2024
Q1 		$249K Sell
480
-8
-2% -$3.98K 0.08% 188
2023
Q4 		$230K Hold
488
– – 0.08% 188
2023
Q3 		$212K Buy
488
+2
+0.4% +$907 0.08% 191
2023
Q2 		$216K Hold
486
– – 0.08% 192
2023
Q1 		$223K Hold
486
– – 0.08% 191
2022
Q4 		$249K Hold
486
– – 0.1% 180
2022
Q3 		$221K Hold
486
– – 0.1% 180
2022
Q2 		$235K Hold
486
– – 0.1% 179
2022
Q1 		$239K Hold
486
– – 0.08% 187
2021
Q4 		$225K Buy
+486
New +$204K 0.07% 198

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Meridian Investment Counsel's ELV Position: Q3 2024 in Review

Meridian Investment Counsel sold out of Elevance Health (ELV) in Q3 2024, closing a stake of 480 shares — an estimated $260K sold.

Meridian Investment Counsel first reported a position in ELV in Q4 2021 and held it in 11 quarters. The position peaked at $260K in Q2 2024. 1,694 funds tracked by Wall St. Rank hold ELV as of Q3 2024.

  • Meridian Investment Counsel reported no remaining Elevance Health position as of Q3 2024 after selling out during the quarter.
  • Meridian Investment Counsel sold 480 Elevance Health shares in Q3 2024, an estimated $260K.
  • Meridian Investment Counsel first reported a position in Elevance Health in Q4 2021 and held it in 11 quarters.
  • Meridian Investment Counsel's Elevance Health position peaked at $260K in Q2 2024.
  • 1,694 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.

Based on Meridian Investment Counsel's 13F filing for Q3 2024, filed 6 Nov 2024.